Heart Focused Movement Effects on Cardiometabolic Risk
Effects of QiGong and Tai Chi (QTC) and Heart Rate Variability Biofeedback (HRVB) on Older Adults' Cardiometabolic Risk
1 other identifier
interventional
22
1 country
1
Brief Summary
This study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV parameters (primary), and cardiometabolic risk factors and sequelae (secondary) (e.g., BMI, waist circumference/percent body fat, sleep quality, stress, anxiety/depression, emotional regulation, eating behaviors, and cognitive performance).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 4, 2021
CompletedFirst Posted
Study publicly available on registry
January 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedFebruary 12, 2024
February 1, 2024
2.6 years
June 4, 2021
February 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Vagal Tone
Measured using resting Heart rate variability and computing parameters of high frequency power and coherence. Will be assessed with participants following a videoguide "to measure their heart rate" that helps them set up equipment and account, seated for 5 minutes of interbeat interval capture using the Inner Balance Bluetooth (HeartMath product) software and earlobe heart beat sensor.
8 Weeks
Secondary Outcomes (12)
Waist circumference
8 Weeks
Abdominal circumference
8 Weeks
Height
8 Weeks
Weight
8 weeks
Perceived stress (Perceived Stress Scale-10)
8 Weeks
- +7 more secondary outcomes
Study Arms (2)
Qigong/Tai Chi Intervention
ACTIVE COMPARATORMeditative movement practice based on qigong and tai chi, delivered via video link
Qigong/Tai Chi (QTC) + Heart Rate Variability (HRVB) Intervention
EXPERIMENTALMeditative movement practice based on qigong and tai chi, delivered via video link with the addition of a brief practice with a the feedback on heart rate variability from an Inner Balance app.
Interventions
Participants will engage in 8 weeks of gentle movement/mindfulness videos provided in a daily text prompt, asking that this be practices most days of the week. A choice of practice video links will be provided, ranging from 10-30 minutes in length, and later confirmation texts will be employed to document if practiced, and what length was chosen.
Randomized participants will be coached to practice a breathing technique that focuses attention on the sensations in the heart area, slowing and deepening the breath, and activating through memory or imagery a positive emotion. This practice is used along with a feedback device that provides information on achievement of the heart rate variability target, "coherence" that represents a neurocardiac state associated with vagal tone, or balance.
Eligibility Criteria
You may qualify if:
- inch or above waist circumference women
- inch or above waist circumference men
- Has a smartphone or tablet
You may not qualify if:
- Those who are unable to stand for 10-minute segments (e.g., wheelchair or walker bound and too weak), and/or unable to walk
- People who have been regularly practicing any form of meditative movement and or HRVB training regularly (i.e., 2 or more times per month for the past 6 months)
- Individuals with diagnosed severe heart arrhythmias, heart transplant, or those with pacemakers would be excluded because either of those interferes with accurately assessing HRV parameters.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arizona State University
Phoenix, Arizona, 85005, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Larkey, PhD
Arizona State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 4, 2021
First Posted
January 18, 2023
Study Start
December 1, 2020
Primary Completion
June 30, 2023
Study Completion
July 31, 2023
Last Updated
February 12, 2024
Record last verified: 2024-02